Fundraising September 15, 2024 – October 1, 2024 About fundraising

Efficacy, patient-reported outcomes, and safety of the...

  • Main
  • 2020 / 10
  • Efficacy, patient-reported outcomes, and safety of the...

Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study

Buckley, Christopher D, Simón-Campos, Jesus A, Zhdan, Vyacheslav, Becker, Brandon, Davy, Katherine, Fisheleva, Elena, Gupta, Anubha, Hawkes, Carol, Inman, David, Layton, Mark, Mitchell, Nina, Patel,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Lancet Rheumatology
DOI:
10.1016/S2665-9913(20)30229-0
Date:
October, 2020
File:
PDF, 687 KB
2020
Conversion to is in progress
Conversion to is failed